Literature DB >> 1551684

Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.

J Xiang1, Z Chen.   

Abstract

Two amino acids, tyrosine at position 96 and histidine at position 99 in the variable heavy chain (VH) CDR3 region of a mouse/human chimeric anti-TAG72 antibody cB72.3-1-3 were substituted with phenylalanine and asparagine respectively by site-directed mutagenesis technique. The expression vector mpSV2neo-EP1-Vm1-3-C gamma 1 containing mutant VH region fragments (Vm1-3) as well as the immunoglobulin enhancer (E), promoter (P1) and human genomic C gamma 1 region fragments, was transfected into a heavy-chain loss mutant cell line B72.3Mut(k). Mutant chimeric cB72.3m1-3 antibodies were purified from the transfectant supernates and compared based upon their binding affinity for the TAG72 antigen relative to that of the original cB72.3-1-3 antibody. The data show that a single amino acid substitution of histidine with asparagine at position 99 in VH CDR3 region contributes to four times increase in binding affinity for the TAG72 antigen. This suggests that the residue at position 99 in VH CDR3 region may play some role in antibody/antigen (B72.3/TAG72) interaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551684      PMCID: PMC1384696     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  Three-dimensional structure of an antigen-antibody complex at 6 A resolution.

Authors:  A G Amit; R A Mariuzza; S E Phillips; R J Poljak
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

2.  Production of functional chimaeric mouse/human antibody.

Authors:  G L Boulianne; N Hozumi; M J Shulman
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

3.  Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.

Authors:  M J Zoller; M Smith
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Single amino acid substitution altering antigen-binding specificity.

Authors:  S Rudikoff; A M Giusti; W D Cook; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas.

Authors:  D Stramignoni; R Bowen; B F Atkinson; J Schlom
Journal:  Int J Cancer       Date:  1983-05-15       Impact factor: 7.396

6.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations.

Authors:  M Nuti; Y A Teramoto; R Mariani-Costantini; P H Hand; D Colcher; J Schlom
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

8.  Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody.

Authors:  D Colcher; M Zalutsky; W Kaplan; D Kufe; F Austin; J Schlom
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

Review 9.  Biological and clinical implications of lymphocyte hybridomas: tumor therapy with monoclonal antibodies.

Authors:  R Levy; R A Miller
Journal:  Annu Rev Med       Date:  1983       Impact factor: 13.739

10.  Galactan-binding antibodies. Diversity and structure of idiotypes.

Authors:  S Rudikoff; M Pawlita; J Pumphrey; E Mushinski; M Potter
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  3 in total

1.  Autologous human B-cell immune response to pulmonary adenocarcinomatous polymorphic epithelial mucin.

Authors:  J Xiang; T Moyana; A Maksymiuk
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

2.  High-affinity chimeric anti-(colorectal carcinoma) antibody correlated to enhanced tumor targeting in biodistribution and imaging.

Authors:  Y Qi; G Matte; A Wilkinson; X Jim
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions.

Authors:  M A Walls; K C Hsiao; L J Harris
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.